SCHEMBL10240580

SCHEMBL10240580

O=S(=O)(Nc1ccc2c(c1)CNCC2)c1ccc(Cl)c2ccccc12

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PNMT P11086 6/20 0.55
HTR6 P50406 5/20 0.53
WDR5 P61964 1/20 0.51
HTR2C P28335 3/20 0.48
DRD2 P14416 1/20 0.48
HTR2A P28223 1/20 0.48
DRD3 P35462 1/20 0.48
ITGA1 P56199 1/20 0.45
HTR2B P41595 2/20 0.44
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 1/20 0.44
KMT2A Q03164 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
SLC2A1 P11166 1/20 0.41
ADRA2A P08913 1/20 0.40
ADRA2B P18089 1/20 0.40
ADRA2C P18825 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9959470 0.99 PNMT (0.54) PNMTHTR6WDR5HTR2CDRD2
SCHEMBL13757767 0.95 HTR6 (0.53) PNMTHTR6WDR5HTR2CDRD2
Hydrochloric Acid SCHEMBL9959618 0.94 HTR6 (0.52) PNMTHTR6WDR5HTR2CDRD2
SCHEMBL3354766 0.93 HTR6 (0.55) PNMTHTR6WDR5HTR2CDRD2
SCHEMBL10238848 0.93 PNMT (0.55) PNMTHTR6WDR5HTR2CDRD2
Hydrochloric Acid SCHEMBL9960393 0.92 PNMT (0.54) PNMTHTR6WDR5HTR2CDRD2
SCHEMBL13757778 0.89 HTR6 (0.52) PNMTHTR6WDR5HTR2CDRD2
Hydrochloric Acid SCHEMBL9960365 0.88 HTR6 (0.51) PNMTHTR6WDR5HTR2CDRD2
SCHEMBL10240571 0.86 HTR6 (0.53) PNMTHTR6HTR2CDRD2HTR2A
SCHEMBL10239980 0.86 HTR6 (0.53) PNMTHTR6HTR2CDRD2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2007729-B1 SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS, THEIR PREPARATION AND USE IN MEDICAMENTS ESTEVE LABOR DR (ES) 2012-06-27 EP disclosed
US-20090209528-A1 SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUND, THEIR PREPARATION AND USE IN MEDICAMENTS LABORATORIOS DEL DR. ESTEVE S.A. (ES) 2009-08-20 US disclosed
US-20090209528-A1 SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUND, THEIR PREPARATION AND USE IN MEDICAMENTS LABORATORIOS DEL DR. ESTEVE S.A. (ES) 2009-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209528-A1 SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUND, THEIR PREPARATION AND USE IN MEDICAMENTS HTR6, HTR5A, HTR7 PNMT 35/4885HTR6 1/4885WDR5 2888/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.